转化生长因子-α在血液透析过程中的水平变化及其临床意义

目的：探讨血清及尿液中转 化生长因子α（ Ｔ Ｇ Ｆα）含量变化对血液 透析（ Ｈ Ｄ） 的影响。方法：采用放 射免疫分析法,对 ４９ 例维持性 Ｈ Ｄ 患者血清 及 １２ 小时 尿液进行 Ｔ Ｇ Ｆα的 水平检测, 以 ３０ 例健康 人作为对 照。结果：与对照组比较, Ｈ Ｄ 前 Ｔ Ｇ Ｆα水平明显降低（ Ｐ＜ ０．０１））。与 Ｈ Ｄ 前比较, Ｈ Ｄ 后 Ｔ Ｇ Ｆα水平增高十 分显著（ Ｐ＜ ０．０５）;１２ 小时尿液中 Ｔ Ｇ Ｆα水平明显高于对照组,有显著性差异（ Ｐ＜ ０．０５）;使用铜仿膜与聚砜膜透析器患者血清 Ｔ Ｇ Ｆα水平明显高于醋酸纤维膜与血仿膜组。结论： Ｔ Ｇ Ｆα水平明显改变参与了 Ｈ Ｄ 患者 的发病机理及病理生理过程;使用铜仿膜和聚砜膜透析器可使 Ｈ Ｄ 患者 Ｔ Ｇ Ｆα含量增高。     

A comparison of T4 and T7 dermatomal levels of analgesia for caesarean section using the lumbar epidural technique

We compared analgesia to the T₄ dermatomal level with analgesia to the T₇ level with and without prophylactic intramuscular administration of ephedrine 25 mg to determine the adequacy and side effects of such analgesia for caesarean section. Unmedicated patients were prehydrated (727 ± 303 ml of saline solution) and kept in a left lateral tilt position. Sufficient three per cent chloroprocaine was given to obtain analgesia to the T₇ (T₆-T₈) dermatomal level (455 ± 128 mg) or to the T₄ (T₃-T₅) dermatomal level (758 ± 168 mg). Patients who received analgesia to the higher level required less narcotic than those who received analgesia to the lower level (21 per cent versus 48 per cent) (p < 0.05). The incidence of hypotension in patients with analgesia at the T₄ level was 21 per cent for those receiving ephedrine and 64 per cent for those who did not receive ephedrine (p < 0.05). Intramuscular administration of ephedrine 25 mg was not associated with increased plasma levels of norepinephrine, epinephrine or dopamine. There was no difference in Apgar score, behavioural test scores, neonatal acid-base status or oxygenation in children of mothers in the different groups. We conclude that a T₄ dermatomal level of analgesia, combined with intramuscular administration of ephedrine 25 mg, provides more maternal comfort than a T₇ level of analgesia does, with or without ephedrine, and is without significant maternal or foetal side effects.     

豆蔻挥发油β-环糊精包含工艺研究

目的：研究豆蔻挥发油β环糊精包合的最佳工艺。方法：正交试验法，考察挥发油利用率指标。结果：优选出包合工艺为：豆蔻挥发油：β环糊精1：8，包合温度50℃，包合时间2h，挥发油利用率为79．7％。结论：此工艺适合大生产。     

液相色谱法测定吗氯贝胺及其多剂量口服后在人体的药动学(英文)

目的 :建立人血浆中吗氯贝胺的反相高效液相色谱检测方法 ,并研究中国健康男性志愿者多剂量口服吗氯贝胺后的药动学特征。方法 :采用反相高效液相色谱法测定人血浆中吗氯贝胺含量。血浆样品在碱性条件下 (pH 11)用二氯甲烷提取处理。色谱柱为 μ BondapakTM C18(12 5 ,10 μm ,3.9mm× 15 0mm)。流动相为乙腈 :0 .0 6 7mol·L- 1磷酸二氢钾溶液 (1∶5 ,V/V ,pH 2 .6 ) ,2 4 0nm检测。内标为甲氧氯普胺。应用 3P97程序拟合药动学参数。结果 :吗氯贝胺在 4 0～ 4 0 0 0 μg·L- 1范围内线性关系良好 (r =0 .9999) ,方法回收率在 99%～10 3%之间 ,日内日间RSD小于 8.14 %。吗氯贝胺血药浓度 时间曲线符合一室模型 ,主要稳态药动学参数Cmax为 (3911± 14 2 ) μg·L- 1;Tmax为 (1.4 2± 0 .2 0 )h ;T1/2 (kel) 为 (2 .6± 0 .3)h ;AUC0 2 4 为(2 2 5 83± 182 1) μg·h·L- 1;MRT为 (4.76± 0 .2 5 )h ;CL/F(s) 为 (2 1.2± 1.2 )L·h- 1。结论 :该方法快速、准确、灵敏度高、专属性强 ,可应用于吗氯贝胺的血药浓度测定     

甲醇合成过程中基于MAS的故障诊断方法

针对甲醇合成生产过程的特点和故障产生机制,将多智能体系统(MA S)技术引入到生产过程的故障诊断中,把生产过程划分为一些相对独立的组件,分派特定的诊断智能体对其进行故障诊断,通过智能体之间的协作,充分利用过程中的局部信息而给出整个过程的故障诊断结果。通过仿真实验,得到了满意的结果。     

Imaging of Vulnerable Plaques Using Near-Infrared Spectroscopy for Risk Stratification of Atherosclerosis

Large randomized trials have shown that lowering the concentration of LDL cholesterol with statins reduces vascular morbidity and mortality rapidly, with further benefit emerging during each year of treatment allocation. But, limited evidence is available about the long-term efficacy and safety of statin treatment. Long-term follow-up of surviving trial participants allows direct assessment of the benefits (and any hazards) of a sustained reduction in LDL cholesterol concentration during the post-trial period. Post-trial follow-up of several large statin trials (of which the Heart Protection Study was the largest) confirms that the substantial absolute benefits and cost-effectiveness of statin therapy were, in fact, underestimated in previous analyses restricted to the “in-trial” periods of randomized studies. Reassuringly, no adverse effects on cancer incidence or non-vascular mortality emerged during the extended follow-up of the Heart Protection Study. These findings support the prompt initiation and long-term continuation of statin therapy in individuals at increased vascular risk.     

Presentation of floating mass transducer and Vibroplasty Couplers on CT and Cone Beam CT

Various titanium coupling elements, Vibroplasty Couplers, maintaining the attachment of the Floating Mass Transducer (FMT) of the active middle ear implant Vibrant Soundbridge (VSB) to the round window, the stapes suprastructure or the stapes footplate are in use to optimally transfer energy from the FMT to the inner ear fluids. In certain cases it is of interest to radiologically verify the correct position of the FMT coupler assembly. The imaging appearance of FMT connected to these couplers, however, is not well known. The aim of this study was to present the radiological appearance of correctly positioned Vibroplasty Couplers together with the FMT using two different imaging techniques. Vibroplasty Couplers were attached to the FMT of a Vibrant Soundbridge and implanted in formalin fixed human temporal bones. Five FMT coupler assemblies were implanted in different positions: conventionally to the incus, a Bell-Coupler, a CliP-Coupler, a Round Window-Coupler and an Oval Window-Coupler. High spatial resolution imaging with Multi-Detector CT (MDCT) and Cone Beam CT (CBCT) was performed in each specimen. Images were blind evaluated by two radiologists on a visual basis. Middle ear details, identification of FMT and coupler, position of FMT coupler assembly and artefacts were assessed. CBCT showed a better spatial resolution and a higher visual image quality than MDCT, but there was no significant advantage over MDCT in delineating the structures or the temporal bone of the FMT Coupler assemblies. The FMT with its coupler element could be clearly identified in the two imaging techniques. The correct positioning of the FMT and all types of couplers could be demonstrated. Both methods, MDCT and CBCT, are appropriate methods for postoperative localization of FMT in combination with Vibroplasty Couplers and for verifying their correct position. If CBCT is available, this method is recommended due to the better spatial resolution and less metal artifacts.     

血管紧张素转换酶基因多态性与高血压微量蛋白尿的关系

为研究血管紧张素转换酶基因插入/缺失（I/D）多态性与高血压微量蛋白尿的关系。应用聚合酶链反应方法扩增50例正常人，50例高血压伴有微量蛋白尿患者和49例高血压不伴有微量蛋白尿患者的白细胞血管紧张素转换酶基因上287bp片段，根据插入（Ⅰ）或/缺失（D）来判断其多态性，用放射免疫法测定所有对象的尿微量白蛋白。结果发现，微量蛋白尿组与健康对照组相比，其D等位基因及DD基因型显著升高。微量蛋白尿组与单纯高血压组相比，其D等位基因及DD基因型显著程式高。单纯高血压组与健康对照组相比，血管紧张素转换酶基因型和等位基因频率无显著性差异。以上提示，血压紧张素转换酶基因多态性与高血压微量蛋白尿有关联性，DD基因型可能与高血压早期肾脏损害有关。